CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Product NDC
- 49527-080
- 11-digit product format
- 495270080
- Labeler code
- 49527
- Product ID
- 49527-080_0818396d-cc21-00ac-e063-6394a90a5d82
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- TITANIUM DIOXIDE, ZINC OXIDE
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- CLINIQUE LABORATORIES LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-09-24
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 24; 59 mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49527-080 | 49527-080-03 | D | Discontinued by firm | 2026-11-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TITANIUM DIOXIDE | 24 mg/mL |
| ZINC OXIDE | 59 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15FIX9V2JP | Internal UNII lookup |
| SOI2LOH54Z | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 884abba1-891d-4c3c-b203-38a5a8a57756 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 30 mL in 1 BOTTLE | LIQUID | 30 | 13 | |
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 5 mL in 1 TUBE | LIQUID | 5 | 13 | |
| 49527-080-03 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 0.2 mL in 1 PACKET | LIQUID | 0.2 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49527-080 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 (TITANIUM DIOXIDE, ZINC OXIDE) LIQUID [CLINIQUE LABORATORIES LLC] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231020_884abba1-891d-4c3c-b203-38a5a8a57756.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Softlips Salted Caramel, Candy Apple, Marshmallow Ghost | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 42cf4623-0eb8-455a-b374-8e17e9336b92 | 2024-12-17 | Warnings | M020 |
| Softlips Peppermint Mocha, Apple Chai Cider, Orange Cranberry | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 0338c078-695d-4d4e-9e90-5a8a98d49524 | 2024-12-17 | Warnings | M020 |
| Softlips Pearl Plus Vanilla | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 107bcaa9-4347-4979-be44-35183a9ee67e | 2024-12-17 | Warnings | M020 |
| Softlips Raspberry | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | d18b4c19-0365-44ec-bea8-4328e537e0d8 | 2024-12-17 | Warnings | M020 |
| Softlips Watermelon | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 03062f13-270d-49cf-8939-2349f12e9cba | 2024-12-17 | Warnings | M020 |
| Softlips Vanilla Watermelon | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | f733747a-ad1a-4222-baf1-69dcd90a3350 | 2024-12-17 | Warnings | M020 |
| Softlips Vanilla Watermelon | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 1fbe85a2-4cd7-45bd-85a2-83bbf75c5f97 | 2024-12-17 | Warnings | M020 |
| Softlips Marshmallow Ghost | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 8d55141d-5d6f-4eec-87dc-d3c808cf7a6a | 2024-12-17 | Warnings | M020 |
| Softlips Pearl | OCTINOXATE, OCTISALATE | The Mentholatum Company | 43e175b4-7a48-431e-bf27-9ce7dee53f5e | 2024-12-17 | Warnings | M020 |
| Softlips Oasis Watermelon Blackberry | DIMETHICONE, OXYBENZONE, OCTINOXATE | The Mentholatum Company | e1213808-4dad-4fd0-871a-04bba094a3cc | 2024-12-17 | Warnings | M020 |
| Softlips Peppermint | DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE | The Mentholatum Company | 1a0062f1-fcfc-4d6a-8274-2ebbc5fbdb27 | 2024-12-17 | Warnings | M020 |
| Softlips Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi | DIMETHICONE, OXYBENZONE, OCTINOXATE | The Mentholatum Company | 7c8a4921-ae45-47fb-a64e-c72b1a386d0d | 2024-12-17 | Warnings | M020 |
| Mentholatum Medicated Lip Balm Cherry | DIMETHICONE, OCTINOXATE, OCTISALATE | The Mentholatum Company | 6edb132d-bb67-4e6c-8e18-db0305073a71 | 2024-12-17 | Warnings | M020 |
| Mentholatum Medicated Lip Balm Original | DIMETHICONE, OCTINOXATE, OCTISALATE | The Mentholatum Company | f84cc3a4-cc9f-4a38-8b7d-cf8d6cd39df1 | 2024-12-17 | Warnings | M020 |
| Mentholatum Natural Ice Sport SPF 30 | AVOBENZONE, DIMETHICONE, OCTINOXATE, OCTISALATE | The Mentholatum Company | 57c35631-42d3-4c6c-bcbb-e2de92b45b13 | 2024-12-17 | Warnings | M020 |
| Mary Kay TimeWise Repair Volu-Firm Day Cream Broad Spectrum SPF 30 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Mary Kay Inc. | 5f09503e-c455-4ac2-8d07-e8e66c2daa32 | 2024-12-17 | Warnings | M020 |
| Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Light to Medium | HOMOSALATE, OCTINOXATE, OXYBENZONE | Mary Kay Inc. | b5ca4bed-4f89-4020-a055-9d11f4cd5058 | 2024-12-17 | Warnings | M020 |
| Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Deep | HOMOSALATE, OCTINOXATE, OXYBENZONE | Mary Kay Inc. | e5fffd20-1d22-485a-9311-4cb4f9264f6f | 2024-12-17 | Warnings | M020 |
| Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Very Deep | HOMOSALATE, OCTINOXATE, OXYBENZONE | Mary Kay Inc. | 404990e4-9499-4186-b39d-afc31834d334 | 2024-12-17 | Warnings | M020 |
| Mary Kay CC Cream Sunscreen Broad Spectrum SPF 15 Medium to Deep | HOMOSALATE, OCTINOXATE, OXYBENZONE | Mary Kay Inc. | 6028e210-a8a3-4d84-a462-16a414c31052 | 2024-12-17 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49527-080-01 | 49527008001 | 1 BOTTLE in 1 CARTON (49527-080-01) / 30 mL in 1 BOTTLE | 1 bottle | 2020-09-24 | 0000-00-00 | No | No | Current |
| 49527-080-02 | 49527008002 | 1 TUBE in 1 CARTON (49527-080-02) / 5 mL in 1 TUBE | 1 tube | 2022-06-06 | 0000-00-00 | No | No | Current |
| 49527-080-03 | 49527008003 | .2 mL in 1 PACKET (49527-080-03) | 2022-11-30 | 0000-00-00 | Yes | No | Current |